Dougados M, Charles-Schoeman C, Szekanecz Z, Giles JT, et al. Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Ann Rheum Dis 2023 Jan 31:ard-2022-223406. doi: 10.1136/ard-2022-223406.
PMID: 36720582